Clinical Trials Directory

Trials / Unknown

UnknownNCT04724876

Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research

Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research (MEMBER Research)

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Beijing Tongren Hospital · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Autoimmune encephalitis (AE) is caused by abnormal immune response mediated by autoimmune antibodies of patients, which can be detected by a serial of autoimmune antibodies\[4,5,6,7\]. At present, the traditional infection diagnosis mainly relies on microbial culture method, which has the characteristics of long cycle, high cost, low detection rate and complex detection process. About 30-60% of encephalitis have unknown etiology\[2,3\]. On the other hand, the diagnosis and classification of noninfectious encephalitis mainly depend on the detection of autoimmune antibodies, the scope of diagnosis and differential diagnosis is limited, and the relationship between autoimmune encephalitis and infection factors is still unclear. Metagenomics sequencing (mNGS) is a new method that does not rely on microbial culture and can directly detect pathogenic nucleic acids. It has the characteristics of fast, accurate, high throughput, no preference for different pathogen detection, and can detect known and unknown pathogens at the same time. Nowadays, mNGS is widely used in the field of pathogen detection.

Conditions

Timeline

Start date
2020-12-31
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2021-01-26
Last updated
2021-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04724876. Inclusion in this directory is not an endorsement.